<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01185392</url>
  </required_header>
  <id_info>
    <org_study_id>CRT Survey</org_study_id>
    <nct_id>NCT01185392</nct_id>
  </id_info>
  <brief_title>European Cardiac Resynchronisation Therapy Survey</brief_title>
  <official_title>European Cardiac Resynchronisation Therapy Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helse Stavanger HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>LivaNova</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roche Diagnostic Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Helse Stavanger HF</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The European CRT survey represents a joint initiative between two ESC associations; the Heart&#xD;
      Failure Association and the European Heart Rhythm Association. The survey will be performed&#xD;
      in collaboration with The Institute für Herzinfarktforschung in Ludwigshafen which will&#xD;
      handle the data collection and data analysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This European CRT Survey was initiated by the Heart Failure Association (HFA) and the&#xD;
      European Heart Rhythm Association (EHRA) of the ESC in order to describe current European&#xD;
      practice and routines associated with CRT-P/CRT-D implantations based on sample of patients&#xD;
      enrolled in 13 countries. The data collected following implantation provides information&#xD;
      including clinical characteristics, diagnostic criteria, implantation routines and&#xD;
      techniques, adverse experience, and assessment of adherence to guideline recommendations. The&#xD;
      single follow-up visit at 1 year (9-15 months) will provide information regarding short-term&#xD;
      clinical outcomes.&#xD;
&#xD;
      The primary objective of this Survey is to describe current European practice based on a&#xD;
      broad sampling in 13 countries. The information collected will enable practice between&#xD;
      centres and countries to be compared and permit benchmarking with national and international&#xD;
      practice. The survey provides valuable quality assurance assessment for individual centres,&#xD;
      permits limited economic analyses and broadly evaluates adherence to guideline&#xD;
      recommendations.&#xD;
&#xD;
      The following 13 European countries contributed patients to the survey: Austria, Belgium,&#xD;
      France, Germany, Ireland, Israel, Italy, the Netherlands, Norway, Spain, Sweden, Switzerland&#xD;
      and UK. Two national coordinators, one each from the fields of heart failure and&#xD;
      electrophysiology, were selected and given the responsibility to facilitate recruitment in&#xD;
      their respective countries.&#xD;
&#xD;
      Follow the link for complete list of the members of the Scientific Committee and national&#xD;
      coordinators.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To describe current European CRT implantation practice and there is a need to precisely quantify the extent of treatment failures, adverse experience and complications associated with implantation.</measure>
    <time_frame>November 2008-October 2010</time_frame>
    <description>The Survey will capture data from patients receiving CRT-P/CRT-D devises:&#xD;
Demographics and clinical characteristics&#xD;
Diagnostic criteria assessed prior to implantation&#xD;
Pharmacological therapy at baseline and follow-up&#xD;
Implantation procedure and techniques&#xD;
Device programming&#xD;
Short and long-term outcomes&#xD;
Adverse experience and hospitalisation&#xD;
Economic analyses&#xD;
Adherence to guidelines&#xD;
These data should also provide information contrasting practice between centres and countries and adherence to guideline recommendations.</description>
  </primary_outcome>
  <enrollment type="Actual">2438</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients successfully implanted with a new CRT-P, CRT-D or upgrades during&#xD;
        the inclusion period were eligible. The successful procedure itself identified the patient&#xD;
        as a survey candidate. Patients screened but not successfully implanted were not entered&#xD;
        into the survey. Ethics approval and written informed consent were obtained in countries&#xD;
        where required.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  eligible patients for CRT-P or CRT-D.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Dickstein, MD, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>HFA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Silvia Priori, MD, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>EHRA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angelo Auricchio, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>EHRA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Josep Brugada, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>EHRA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Cleland, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>HFA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Geneviève Derumeaux, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>EAE of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Gras, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>EHRA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel Komajda, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>HFA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cecilia Linde, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>EHRA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Morgan, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>EHRA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dirk J van Veldhuisen, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>HFA of the ESC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anselm Gitt, MD</last_name>
    <role>Study Director</role>
    <affiliation>The Institut für Herzinfarktforschung in Ludwigshafen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nigussie Bogale, MD</last_name>
    <role>Study Director</role>
    <affiliation>Stavanger University Hospital and University of Bergen, Norway</affiliation>
  </overall_official>
  <link>
    <url>http://www.crt-survey.org</url>
    <description>Synopsis of the Survey, list of participating countries and members of the Scientific Committee and national coordinators</description>
  </link>
  <reference>
    <citation>CRT Survey Scientific Committee. European cardiac resynchronization therapy survey: rationale and design. Eur J Heart Fail. 2009 Mar;11(3):326-30. doi: 10.1093/eurjhf/hfp030. Review.</citation>
    <PMID>19228801</PMID>
  </reference>
  <results_reference>
    <citation>Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J; Scientific Committee; National Coordinators. The European cardiac resynchronization therapy survey. Eur Heart J. 2009 Oct;30(20):2450-60. doi: 10.1093/eurheartj/ehp359. Epub 2009 Aug 31.</citation>
    <PMID>19723694</PMID>
  </results_reference>
  <verification_date>June 2012</verification_date>
  <study_first_submitted>August 7, 2010</study_first_submitted>
  <study_first_submitted_qc>August 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2010</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Resynchronisation Therapy in Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

